Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
LEDIKAST 90/400 is a prescription antiviral medication containing Ledipasvir (90 mg) and Sofosbuvir (400 mg). It is used to treat chronic Hepatitis C Virus (HCV) infection in adults and children aged 3 and older by blocking the virus from multiplying, which helps clear the infection and prevent liver damage.
| Strength | 90/400 |
| Uses | Chronic Hepatitis C (Genotypes 1, 4, 5, 6) |
| Packaging Size | 28 Tablets |
| Main Ingredients | 90 mg Ledipasvir + 400 mg Sofosbuvir |
| Shelf life | 24 months |
| Storage | Store below 30°C |